Tag: immune checkpoint inhibitors

Updated 2026 expert recommendations provide a comprehensive, evidence-graded framework for preventing, diagnosing and treating the rare but often fatal myocarditis ...

The prospective SARC-LUNG study links circulating immunometabolic biomarkers such as sRAGE and FGF21 with survival and immune microenvironment profiles in ...

A new Perspective argues that next-generation oncolytic viruses act as antigen-agnostic in situ vaccines capable of priming de novo antitumor ...

Adelaide University researchers have developed mRNA lipid nanoparticles that reprogram immunosuppressive tumour-associated macrophages to recruit cancer-fighting T cells, showing reduced ...

A new review explains how radiation-induced CCL2/CCR2 signaling recruits immunosuppressive myeloid cells and remodels the tumor microenvironment, and why combining ...

Brain metastases strike up to 30 percent of cancer patients, bringing headaches, seizures, neurological deficits and a median survival of ...

A comprehensive review finds that patient-derived tumor organoid co-culture with immune cells offers the most physiologically faithful platform yet for ...

Cancer immunotherapy is entering a new phase in which the goal is no longer simply to “release the brakes” on ...

A real-world study of patients with unresectable advanced melanoma in China has found that adding the cancer drug anlotinib to ...

Irvine, Calif., Aug. 20, 2026 — Immunotherapy has changed the outlook for many people with advanced cancer by turning the ...